Sigrid Godelieve Victor Cornelis

Title: Sigrid Godelieve Victor Cornelis: Innovator in Biological Materials

Introduction

Sigrid Godelieve Victor Cornelis is a notable inventor based in Sint-Martens-Latem, Belgium. He has made significant contributions to the field of biological materials, particularly in relation to HER3. With a total of two patents to his name, Cornelis is recognized for his innovative approaches in biotechnology.

Latest Patents

Cornelis's latest patents focus on amino acid sequences directed against HER3. These patents encompass compounds or constructs, including proteins and polypeptides that consist of these amino acid sequences. The disclosures also cover nucleic acids encoding such sequences and polypeptides, methods for their preparation, and host cells capable of expressing them. Furthermore, the patents detail pharmaceutical compositions that include these amino acid sequences, polypeptides, nucleic acids, and host cells, highlighting their potential uses for prophylactic, therapeutic, or diagnostic purposes.

Career Highlights

Cornelis is currently associated with Ablynx N.V., a company known for its innovative biopharmaceuticals. His work at Ablynx has allowed him to explore and develop groundbreaking solutions in the field of biotechnology. His contributions have been instrumental in advancing the understanding and application of biological materials.

Collaborations

Some of his notable coworkers include Christine Knuehl and Bjoern Hock. Their collaborative efforts contribute to the innovative environment at Ablynx, fostering advancements in biopharmaceutical research.

Conclusion

Sigrid Godelieve Victor Cornelis stands out as an influential inventor in the realm of biological materials related to HER3. His patents and work at Ablynx N.V. reflect his commitment to advancing biotechnology for therapeutic applications.